Sfoglia per Autore
Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat
2008-01-01 O. MURCH; M. ABDELRAHMAN; M. COLLINO; M. GALLICCHIO; E. BENETTI; E. MAZZON; R. FANTOZZI; S. CUZZOCREA; C. THIEMERMANN
Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction
2008-01-01 Tripatara P; Sa Patel N; Collino M; Gallicchio M; Kieswich J; Castiglia S; Benetti E; Stewart KN; Brown PA; Yaqoob MM; Fantozzi R; Thiemermann C.
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses
2008-01-01 Di Nicolantonio F ; Arena S; Gallicchio M; Zecchin D; Martini M; Flonta SE; Stella GM; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A
Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression
2008-01-01 DIANZANI C; BRUCATO L; GALLICCHIO M; ROSA AC; COLLINO M; FANTOZZI R
Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29)
2008-01-01 M GALLICCHIO; AC ROSA; C DIANZANI; L BRUCATO; E BENETTI; M COLLINO; R FANTOZZI
Substance P-induced cycloxygenase-2 expression in polymorphonuclear cells
2008-01-01 M. GALLICCHIO; E. BENETTI; AC. ROSA; R. FANTOZZI
Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.
2009-01-01 Gallicchio M; Benetti E; Rosa AC; Fantozzi R
Antiapoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional mycardial I/R
2009-01-01 A. Sivarajah; M. Collino; M. Yasin; E. Benetti; M. Gallicchio; E. Mazzon; S. Cuzzocrea; R. Fantozzi; C. Thiemermann
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES
2009-01-01 Gallicchio M; Di Nicolantonio F; Arena S.; Zecchin D; Martini M; Flonta S; Stella G; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A.
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.
2010-01-01 Di Nicolantonio F; Arena S; Tabernero J; Grosso S; Molinari F; Macarulla T; Russo M; Cancelliere C; Zecchin D; Mazzucchelli L; Sasazuki T; Shirasawa S; Geuna M; Frattini M; Baselga J; Gallicchio M; Biffo S; Bardelli A
Isogenic mutant human cells: a new tool for personalized cancer medicine
2010-01-01 Di Nicolantonio F; Arena S; Gallicchio M; Bardelli A
Knock in of cancer mutations in human cells predicts pharmacologicalresponse to targeted therapies
2011-01-01 Valentina Boscaro; Davide Zecchin; Federica Di Nicolantonio; Alberto Bardelli; Margherita Gallicchio
Modeling tumor progression and identifying genotype-drug interactions by the sequential introduction of cancer mutations into the genome of human normal cells
2011-01-01 Davide Zecchin; Margherita Gallicchio; Valentina Boscaro; Francesco Sassi; Enzo Medico; Federica Di Nicolantonio; Alberto Bardelli.
Isogenic K-Ras mutant cancer cells: A novel platform for drug profiling
2011-01-01 Goodall J; Hunt J; Chen Z; Di Nicolantonio F; Gallicchio M; Lamba S; Bardelli A; Mahoney C; Astley H; Torrance C; Grimshaw K
EMERGENCE OF KRAS MUTATIONS AND ACQUIRED RESISTANCE TO ANTI EGFR THERAPY IN COLORECTAL CANCER
2012-01-01 Misale S; Yaeger R; Hobor S; Scala E; Janakiraman M; Liska D; Valtorta E; Schiavo R; Buscarino M; Siravergna G; Bencardino K; Cercek A; Chen C; Veronese S; Zanon C; Sartore-Bianchi A; Gambacorta M; Gallicchio M; Vakiani E; Boscaro V; Medico E; Weiser M; Siena S; di Nicolantonio F; Solit D; Bardelli A
Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer
2012-01-01 Misale, S; Yaeger, R; Hobor, S; Scala, E; Janakiraman, M; Liska, D; Valtorta, E; Schiavo, R; Buscarino, M; Siravegna, G; Bencardino, K; Cercek, A; Chen, Ct; Veronese, S; Zanon, C; Sartore-Bianchi, A; Gambacorta, M; Gallicchio, M; Vakiani, E; Boscaro, V; Medico, E; Weiser, M; Siena, S; Di Nicolantonio, F; Solit, D; Bardelli, A.
BRAF V600E is a determinant of sensitivity to proteasome inhibitors.
2013-01-01 Zecchin D;Boscaro V;Medico E;Barault L;Martini M;Arena S;Cancelliere C;Bartolini A;Crowley EH;Bardelli A;Gallicchio M;Di Nicolantonio F
Antiproliferative Effects of new Vanadyl Complexes with Acetilacetonate Derivatives on non-Tumor and Tumor Cell Lines
2013-01-01 V. Boscaro; S. Sgarbossa; E. Diana; D. Marabello; A. Deagostino; S. Cadamuro; A. Barge; E. Laurenti; E. Ghibaudi;M. Gallicchio
Unveiling of BRAF V600E Mutant Cells Sensitivity to Proteasome Inhibitors Using an Isogenic Cell Based Screening
2013-01-01 V. Boscaro; D. Zecchin; A. Bardelli; F. Di Nicolantonio; M. Gallicchio
SYNTHESIS, CHARACTERIZATION AND CELL VIABILITY TEST OF SIX VANADYL COMPLEXES WITH ACETYLACETONATE DERIVATIVES
2013-01-01 S.Sgarbossa; E.Diana; D.Marabello; A.Deagostino; S.Cadamuro; A. Barge; E.Laurenti; M.Gallicchio; V.Boscaro; E.Ghibaudi
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat | 2008 | O. MURCH; M. ABDELRAHMAN; M. COLLINO; M. GALLICCHIO; E. BENETTI; E. MAZZON; R. FANTOZZI; S. CUZZOCREA; C. THIEMERMANN | |
| Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction | 2008 | Tripatara P; Sa Patel N; Collino M; Gallicchio M; Kieswich J; Castiglia S; Benetti E; Stewart KN; Brown PA; Yaqoob MM; Fantozzi R; Thiemermann C. | |
| Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses | 2008 | Di Nicolantonio F ; Arena S; Gallicchio M; Zecchin D; Martini M; Flonta SE; Stella GM; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A | |
| Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression | 2008 | DIANZANI C; BRUCATO L; GALLICCHIO M; ROSA AC; COLLINO M; FANTOZZI R | |
| Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29) | 2008 | M GALLICCHIO; AC ROSA; C DIANZANI; L BRUCATO; E BENETTI; M COLLINO; R FANTOZZI | |
| Substance P-induced cycloxygenase-2 expression in polymorphonuclear cells | 2008 | M. GALLICCHIO; E. BENETTI; AC. ROSA; R. FANTOZZI | |
| Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes. | 2009 | Gallicchio M; Benetti E; Rosa AC; Fantozzi R | |
| Antiapoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional mycardial I/R | 2009 | A. Sivarajah; M. Collino; M. Yasin; E. Benetti; M. Gallicchio; E. Mazzon; S. Cuzzocrea; R. Fantozzi; C. Thiemermann | |
| EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES | 2009 | Gallicchio M; Di Nicolantonio F; Arena S.; Zecchin D; Martini M; Flonta S; Stella G; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A. | |
| Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. | 2010 | Di Nicolantonio F; Arena S; Tabernero J; Grosso S; Molinari F; Macarulla T; Russo M; Cancelliere C; Zecchin D; Mazzucchelli L; Sasazuki T; Shirasawa S; Geuna M; Frattini M; Baselga J; Gallicchio M; Biffo S; Bardelli A | |
| Isogenic mutant human cells: a new tool for personalized cancer medicine | 2010 | Di Nicolantonio F; Arena S; Gallicchio M; Bardelli A | |
| Knock in of cancer mutations in human cells predicts pharmacologicalresponse to targeted therapies | 2011 | Valentina Boscaro; Davide Zecchin; Federica Di Nicolantonio; Alberto Bardelli; Margherita Gallicchio | |
| Modeling tumor progression and identifying genotype-drug interactions by the sequential introduction of cancer mutations into the genome of human normal cells | 2011 | Davide Zecchin; Margherita Gallicchio; Valentina Boscaro; Francesco Sassi; Enzo Medico; Federica Di Nicolantonio; Alberto Bardelli. | |
| Isogenic K-Ras mutant cancer cells: A novel platform for drug profiling | 2011 | Goodall J; Hunt J; Chen Z; Di Nicolantonio F; Gallicchio M; Lamba S; Bardelli A; Mahoney C; Astley H; Torrance C; Grimshaw K | |
| EMERGENCE OF KRAS MUTATIONS AND ACQUIRED RESISTANCE TO ANTI EGFR THERAPY IN COLORECTAL CANCER | 2012 | Misale S; Yaeger R; Hobor S; Scala E; Janakiraman M; Liska D; Valtorta E; Schiavo R; Buscarino M; Siravergna G; Bencardino K; Cercek A; Chen C; Veronese S; Zanon C; Sartore-Bianchi A; Gambacorta M; Gallicchio M; Vakiani E; Boscaro V; Medico E; Weiser M; Siena S; di Nicolantonio F; Solit D; Bardelli A | |
| Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer | 2012 | Misale, S; Yaeger, R; Hobor, S; Scala, E; Janakiraman, M; Liska, D; Valtorta, E; Schiavo, R; Buscarino, M; Siravegna, G; Bencardino, K; Cercek, A; Chen, Ct; Veronese, S; Zanon, C; Sartore-Bianchi, A; Gambacorta, M; Gallicchio, M; Vakiani, E; Boscaro, V; Medico, E; Weiser, M; Siena, S; Di Nicolantonio, F; Solit, D; Bardelli, A. | |
| BRAF V600E is a determinant of sensitivity to proteasome inhibitors. | 2013 | Zecchin D;Boscaro V;Medico E;Barault L;Martini M;Arena S;Cancelliere C;Bartolini A;Crowley EH;Bardelli A;Gallicchio M;Di Nicolantonio F | |
| Antiproliferative Effects of new Vanadyl Complexes with Acetilacetonate Derivatives on non-Tumor and Tumor Cell Lines | 2013 | V. Boscaro; S. Sgarbossa; E. Diana; D. Marabello; A. Deagostino; S. Cadamuro; A. Barge; E. Laurenti; E. Ghibaudi;M. Gallicchio | |
| Unveiling of BRAF V600E Mutant Cells Sensitivity to Proteasome Inhibitors Using an Isogenic Cell Based Screening | 2013 | V. Boscaro; D. Zecchin; A. Bardelli; F. Di Nicolantonio; M. Gallicchio | |
| SYNTHESIS, CHARACTERIZATION AND CELL VIABILITY TEST OF SIX VANADYL COMPLEXES WITH ACETYLACETONATE DERIVATIVES | 2013 | S.Sgarbossa; E.Diana; D.Marabello; A.Deagostino; S.Cadamuro; A. Barge; E.Laurenti; M.Gallicchio; V.Boscaro; E.Ghibaudi |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile